Company intelligence / Profile preview

Ubie

Ownership: Private
Development stage: Other

Overview

Ubie’s AI Symptom Checker has been used by over 4 million users in the US and guides more than 10 million patients globally each month to seek appropriate medical attention. The platform has demonstrated significant impact on patient quality-adjusted life years and economic value. It leverages data from over 50,000 peer-reviewed publications and input from more than 50 medical specialists.

Therapeutic areas: Other
Modalities: Non-pharmacological therapy (AI-powered digital health tools; not a drug developer)
Industry: Digital Health Medical Devices

Partnerships

Mayo Clinic Platform Accelerate program participantStrategic investment from GooglePartnerships with patient advocacy groupsWorks with “70% of the world’s top life science companies” for marketing solutions

Beyond the preview

Go deeper on Ubie.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubie.

Explore the full profile